Lentigen

We develop, optimize, and engineer robust, GMP-compliant cell manufacturing processes that are specifically tailored to our customers’ cell therapy needs. We are known for our unparalleled commitment to innovation and technical excellence, drawing on our own time-tested technologies and resources. We are a division of Miltenyi Biotec, a pioneering innovator and provider of cell processing and analytical platforms, LVVs, and ancillary materials in this field. Our mission is to improve the availability and affordability of advanced CGT products. We provide services, expertise, and technologies to leading researchers, biotech companies, and large corporates to take their cell and gene therapy products to the next level. With our expertise, breakthrough platforms, and tailored service offerings, Miltenyi Bioindustry helps from early clinical trials to large-scale global operations. With this, Miltenyi Bioindustry is able to offer an all-inclusive platform and service package to add true value to your therapy products. Our acquisition and integration of the lentiviral vector manufacturing business from Lentigen, and Living Pharma’s CAR T cell therapy technology, has strengthened this still further, allowing us to offer lentiviral vector and cell manufacturing services on a larger scale.